CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-15 | DeVinney Erick Wayne VP Peripheral Nerve Science | Option exercise · Employee Stock Option (right to buy) | −10,000 | 0 | ||
| 2021-11-24 | Zaderej Karen L. CEO | Option exercise | +52,375 | $8.95 | $469K | 921,147 |
| 2021-11-24 | Zaderej Karen L. CEO | Option exercise · Employee Stock Option (right to purchase) | −52,375 | $8.95 | $469K | 157,125 |
| 2021-08-13 | Zaderej Karen L. CEO | Option exercise | +46,500 | $3.67 | $171K | 868,772 |
| 2021-08-13 | Zaderej Karen L. CEO | Option exercise · Employee Stock Option (right to buy) | −46,500 | $3.67 | $171K | 0 |
| 2021-08-12 | Zaderej Karen L. CEO | Option exercise | +8,254 | $5.09 | $42K | 822,272 |
| 2021-08-12 | Zaderej Karen L. CEO | Option exercise · Employee Stock Option (right to buy) | −8,254 | $5.09 | $42K | 26,746 |
| 2021-08-10 | Zaderej Karen L. CEO | Option exercise | +75,000 | $5.09 | $382K | 855,018 |
| 2021-08-10 | Zaderej Karen L. CEO | Option exercise · Employee Stock Option (right to purchase) | −75,000 | $5.09 | $382K | 35,000 |
| 2021-08-06 | Zaderej Karen L. CEO | Sale | −14,756 | $18.40 | $272K | 840,262 |
| 2021-08-06 | Zaderej Karen L. CEO | Sale | −1,259 | $19.18 | $24K | 839,003 |
| 2021-08-06 | Zaderej Karen L. CEO | Sale | −22,902 | $18.41 | $422K | 816,101 |
| 2021-08-06 | Zaderej Karen L. CEO | Sale | −2,083 | $19.16 | $40K | 814,018 |
| 2021-07-21 | Donovan Michael Patrick VP Operations | Sale | −1,935 | $20.04 | $39K | 40,839 |
| 2021-07-20 | DeVinney Erick Wayne VP Peripheral Nerve Science | Shares withheld for taxes | −392 | $19.20 | $8K | 80,426 |
| 2021-07-20 | Donovan Michael Patrick VP Operations | Shares withheld for taxes | −637 | $19.20 | $12K | 42,774 |
| 2021-07-20 | Zaderej Karen L. CEO | Shares withheld for taxes | −8,812 | $19.20 | $169K | 780,018 |
| 2021-07-20 | Sandberg Eric Chief Commercial Officer | Shares withheld for taxes | −1,090 | $19.20 | $21K | 6,541 |
| 2021-07-20 | Scopelianos Angelo Chief R&D Officer | Shares withheld for taxes | −637 | $19.20 | $12K | 10,120 |
| 2021-07-20 | MARIANI PETER J EVP & Chief Financial Officer | Shares withheld for taxes | −918 | $19.20 | $18K | 21,026 |
Page 32 of 69 · 1,376 trades